NHS England has initiated the world's first gonorrhoea vaccination program, targeting high-risk populations to reduce cases of the sexually transmitted infection. Diagnoses of gonorrhoea in 2023 reached 85,000, the highest on record. This initiative uses the existing meningococcal disease vaccine, 4CMenB, which offers protection against gonorrhoea. Eligible candidates primarily include gay and bisexual men with a history of multiple sexual partners and other bacterial STIs. The program may save the NHS up to £7.9 million over a decade while enhancing public health measures against STIs.
The vaccination program is a world-first aimed at curbing gonorrhoea cases, with NHS England seeking to protect thousands from this sexually transmitted infection.
In 2023, diagnoses of gonorrhoea reached 85,000, the highest levels since records began, prompting the rollout of a vaccine to combat rising cases.
The vaccine, which is based on the existing meningococcal disease vaccine, can be offered free to those most at risk, including gay and bisexual men.
The new program could save the NHS up to £7.9 million over the next decade, marking a significant advancement in public health.
Collection
[
|
...
]